SCIENTIFIC AGENDA

About the Multiple Myeloma Scientific Agenda

Developed by the Multiple Myeloma Research Foundation, with the help of the broader scientific community, the Multiple Myeloma Scientific Agenda is a three-year plan to bring new and combination therapies to patients as quickly as possible while rapidly advancing our understanding of the disease.

Why the Scientific Agenda was developed

With the advent of new scientific advances-such as genomics, proteomics, and the development of new technologies-scientists are now equipped with new tools to advance research efforts that did not exist just a few years ago. Recognizing the tremendous opportunities these scientific and technological advances present, the MMRF sought to evolve its Scientific Agenda to apply these exciting advances to the field of myeloma. This would ensure that we maximize each dollar raised by funding innovative research efforts that offer the greatest potential to advance myeloma research and drug discovery.

2009 Scientific Agenda

In updating this cutting-edge research plan for 2009, we undertook a rigorous process to prioritize key research areas. This systematic process included extensive one-on-one interviews and collaborative teleconferences with technology pioneers and, most recently, a novel Research Roundtable comprised of an extraordinary assembly of academic scientists, industry, and the National Institutes of Health (NIH).